In cancer treatment, the presence of impurities in pharmaceuticals or medical devices can impact their safety and efficacy. Impurities in drugs may lead to adverse effects, reduced therapeutic effectiveness, or increased toxicity. Regulatory bodies like the FDA have stringent guidelines to limit impurities in cancer medications to ensure patient safety. Furthermore, the stability and quality of cancer drugs can be compromised by impurities, potentially affecting treatment outcomes.
